Alpha Tau Medical Ltd (DRTS) Price Prediction & ForecastDRTSAlpha Tau Medical Ltd

Alphio's DRTS stock price prediction model matches the current Alpha Tau Medical Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.40 (-0.59%). The 1-week path is $12.91 (-4.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Alpha Tau Medical Ltd (DRTS) is not a good buy. The stock is trading at $12.29, with a significant recent decline of 14.71% over the last five days and a staggering 19.36% over the last 20 days. The RSI is at a low 13.697, indicating that the stock is oversold. Furthermore, the company has reported increasing losses, with a net income of -45,813,000 USD in Q2 2026 and an EPS of -0.50, which raises concerns about its financial health. The main risk is the ongoing negative earnings trend, with a forward P/E ratio of 0, indicating no expected profitability in the near term. Given these factors, it is advisable to sell rather than buy at this time.

Alpha Tau Medical Ltd (DRTS) last closed at $13.48, gaining +2.98%. These facts feed the 1-day and 1-week DRTS price prediction above.